For a defense contractor, a record-breaking order book is typically a powerful catalyst for share price appreciation. In the case of Hensoldt, however, this very strength is presenting a significant operational challenge. The company is grappling with a situation where customer demand is outpacing its manufacturing capabilities, raising a critical question for investors: Can the company scale its production swiftly enough to convert its substantial backlog into revenue?
A Manufacturing Bottleneck Amid Record Demand
The core of the issue lies in Hensoldt’s remarkable 2025 performance in securing new business. The company reported the highest order intake in its history, reaching €4.71 billion—a substantial 62% increase over the previous year. Consequently, the total order backlog swelled by one-third to €8.83 billion. This figure now stands at more than three times the company’s annual revenue.
Key drivers for this surge included major contracts for air defense radar systems, the Eurofighter program, and the P-8 Poseidon aircraft. A particularly strong performance was noted in the Optronics segment, where incoming orders more than doubled. Revenue in this division grew by 20% to €419 million.
This success has created a fundamental tension. While the order book is overflowing, industrial capacity is struggling to keep pace. As a result, the market’s focus has shifted from the volume of new orders to the speed and efficiency with which Hensoldt can fulfill them.
2025 Financial Performance: Solid Foundations with a Q4 Slowdown
Operationally, 2025 delivered solid results. Group revenue advanced by 9.6% to €2.455 billion. Adjusted EBITDA rose to €452 million, with the corresponding margin reaching 18.4%, exceeding the company’s own target of at least 18%.
The adjusted free cash flow also showed improvement, climbing to €347 million from €249 million in the prior year, and came in above guidance. This was supported by operational performance and advance customer payments. The net debt-to-EBITDA ratio remained at a manageable level of 1.6x.
A slight dampener was the final quarter of the year. Fourth-quarter revenue fell approximately 4% short of analyst consensus estimates. The deviation was around 5% in the Sensors segment, reinforcing the narrative that not all contracted business translates immediately into deliveries.
Should investors sell immediately? Or is it worth buying Hensoldt?
2026 Guidance: Growth Maintained Amid Cautious Expectations
Looking ahead, Hensoldt has provided revenue guidance of approximately €2.75 billion for 2026, alongside an adjusted EBITDA margin forecast of 18.5% to 19%. The midpoint of this revenue outlook was perceived as conservative, sitting about 2% below the prevailing analyst consensus at the time of the report.
Simultaneously, the company reaffirmed its target for a book-to-bill ratio between 1.5 and 2.0. The underlying message remains consistent: demand is not the issue; the bottleneck is production. To address this workload, Hensoldt plans to create around 1,600 new positions in 2026. With a current workforce of roughly 9,000, this represents a headcount increase of nearly 18%.
Shareholders can expect a modest dividend increase, with a proposed payout of €0.55 per share, roughly 10% higher than the previous year.
On the leadership front, the Supervisory Board extended the contract of CEO Oliver Dörre until the end of 2031 on February 24, 2026. The company’s “North Star” strategy focuses on scaling production, expanding its software business, and pursuing a targeted internationalization plan.
Market Sentiment Weighed Down by Capacity Concerns
The current market valuation reflects these operational headwinds. At a recent price of €77.05, shares were down 1.47%. The stock continues to trade below both its 50-day moving average of €83.18 and its 200-day moving average of €88.30. This technical picture suggests that, for now, capacity constraints are carrying more weight with investors than the record order intake.
Investors will be watching for tangible progress. Hensoldt is scheduled to publish its audited financial statements on March 26, 2026, with preliminary figures for the first quarter of 2026 expected on May 6, 2026. The critical factor in the interim will be the company’s ability to translate its announced scaling efforts into measurable delivery milestones.
Ad
Hensoldt Stock: Buy or Sell?! New Hensoldt Analysis from April 4 delivers the answer:
The latest Hensoldt figures speak for themselves: Urgent action needed for Hensoldt investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 4.
Hensoldt: Buy or sell? Read more here...
